Metabolic and bariatric surgery for patients with obesity type 1 diabetes mellitus: A comprehensive updated systematic review and meta‐analysis
MBS achieves weight loss and reduces insulin requirements in adults with type 1 diabetes mellitus and obesity, but glycaemic improvements are minimal. Given the observational evidence base and inconsistent safety reporting, true metabolic risk remains uncertain. High-quality prospective studies with standardised outcome definitions are needed.
Authors
- Roland H. Stimson (ORCID: https://orcid.org/0000-0002-9002-6188)
- James Lucocq (ORCID: https://orcid.org/0000-0002-6979-7818)
- Andrew G. Robertson (ORCID: https://orcid.org/0000-0002-9734-5368)
- PJ Lamb
- Sebastian Mitchell
- Ketaki Patwardhan
- Georgios Geropoulos
- Omar Ghanem
Institutions
- NHS Lothian (GB)
- Edinburgh Royal Infirmary (GB)
- Mayo Clinic in Florida (US)
- The Queen's Medical Research Institute (GB)
Publication Details
- Journal
- Diabetic Medicine
- Published
- 2026-03-28
- DOI
- https://doi.org/10.1111/dme.70305
- Primary Topic
- Bariatric Surgery and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00